ArticleResearch and reports in urology2025

Performance of PCA3 and TMPRSS2:ERG Within the Prostate Cancer Prevention Trial Risk Calculator Version 2 in a Lithuanian Cohort.

Jurate Kemesiene et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.